PCI Biotech Holding Logo

PCI Biotech Holding

Biopharma firm evaluating its future after discontinuing its core technology development.

PCIB | OL

Overview

Corporate Details

ISIN(s):
NO0010405640
LEI:
5967007LIEEXZXFIGG77
Country:
Norway
Address:
Ullernchausséen 64, 0379 OSLO
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

PCI Biotech Holding is a biopharmaceutical company that was focused on developing a proprietary photochemical technology platform. This platform was designed to enhance intracellular drug delivery for therapeutic applications, including immunotherapy and dermatology, and to advance the bioprocessing and manufacturing of viral vectors for gene therapy. In August 2025, the company announced the discontinuation of its core technology development. Consequently, PCI Biotech is currently evaluating its future operations and strategic direction.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-23 10:35
Business and Financial Review
PCI Biotech update
English 3.6 KB
2025-09-25 15:36
Business and Financial Review
PCI Biotech update on future operations
English 3.6 KB
2025-08-26 16:14
Report Publication Announcement
PCI Biotech: Invitation to first half 2025 results presentation and corporate u…
English 2.3 KB
2025-08-22 14:15
Major Shareholding Notification
Flaggemelding
Norwegian 411 bytes
2025-08-22 11:09
Major Shareholding Notification
Flaggemelding
Norwegian 451 bytes
2025-08-18 20:39
Regulatory News Service
PCI Biotech announces discontinuation of development of the PCL technology and …
English 3.4 KB
2025-05-22 09:45
Post-Annual General Meeting Information
PCI Biotech: Minutes of Annual General Meeting 2025
Norwegian 449.8 KB
2025-05-22 09:45
Post-Annual General Meeting Information
PCI Biotech: Minutes of Annual General Meeting 2025
English 866 bytes
2025-05-20 20:08
Declaration of Voting Results & Voting Rights Announcements
PCI BIotech: Disclosure of voting rights for Chair of the Board
English 1.2 KB
2025-04-30 08:00
Pre-Annual General Meeting Information
Notice of Annual General Meeting 2025
Norwegian 188.6 KB
2025-04-30 08:00
Pre-Annual General Meeting Information
Notice of Annual General Meeting 2025
Norwegian 146.9 KB
2025-04-30 08:00
Pre-Annual General Meeting Information
Notice of Annual General Meeting 2025
English 167.8 KB
2025-04-30 08:00
Pre-Annual General Meeting Information
Notice of Annual General Meeting 2025
English 208.0 KB
2025-04-30 08:00
Pre-Annual General Meeting Information
Notice of Annual General Meeting 2025
English 977 bytes
2025-04-24 15:30
Annual Report (ESEF)
PCI Biotech Holding ASA: Annual Report 2024
English 5.4 MB

Automate Your Workflow. Get a real-time feed of all PCI Biotech Holding filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PCI Biotech Holding

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PCI Biotech Holding via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

DIGITAL HOLDINGS,INC. Logo
Drives business DX with data-driven advertising, CRM consulting, and AI integration.
Japan
2389
DIGITALIFT Inc. Logo
Digital marketing firm providing programmatic ad operations and strategic consulting services.
Japan
9244
D.L.S.I. Logo
HR and recruitment services for temp, fixed-term, and permanent roles across industries.
France
ALDLS
Dogwood Therapeutics, Inc. Logo
Developing non-opioid therapeutics for neuropathic pain, fibromyalgia, and cancer-related pain.
United States of America
DWTX
Investment firm leasing four Airbus A380s to Emirates for shareholder returns.
Guernsey
DNA3
Acquires, leases, and sells Boeing 787-8 aircraft to commercial airlines for investors.
Guernsey
DPA
DreamCIS INC. Logo
A CRO providing clinical research services for pharma, biotech, and medical device industries.
South Korea
223250
DT&CRO CO., Ltd. Logo
A full-service CRO for pharma & biotech, from non-clinical studies to FDA approval support.
South Korea
383930
DUSKIN CO.,LTD. Logo
Franchises cleaning rentals and services for homes and businesses, and operates food chains.
Japan
4665
D.Western Therapeutics Institute, Inc. Logo
Biotech firm discovering and licensing drug candidates, focusing on kinase inhibitors.
Japan
4576

Talk to a Data Expert

Have a question? We'll get back to you promptly.